195 related articles for article (PubMed ID: 16159809)
1. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
Gyöngyösi M; Khorsand A; Zamini S; Sperker W; Strehblow C; Kastrup J; Jorgensen E; Hesse B; Tägil K; Bøtker HE; Ruzyllo W; Teresiñska A; Dudek D; Hubalewska A; Rück A; Nielsen SS; Graf S; Mundigler G; Novak J; Sochor H; Maurer G; Glogar D; Sylven C
Circulation; 2005 Aug; 112(9 Suppl):I157-65. PubMed ID: 16159809
[TBL] [Abstract][Full Text] [Related]
2. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
Kastrup J; Jørgensen E; Rück A; Tägil K; Glogar D; Ruzyllo W; Bøtker HE; Dudek D; Drvota V; Hesse B; Thuesen L; Blomberg P; Gyöngyösi M; Sylvén C;
J Am Coll Cardiol; 2005 Apr; 45(7):982-8. PubMed ID: 15808751
[TBL] [Abstract][Full Text] [Related]
3. Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.
Charwat S; Lang I; Dettke M; Graf S; Nyolczas N; Hemetsberger R; Zamini S; Khorsand A; Sochor H; Maurer G; Glogar D; Gyöngyösi M
Thromb Haemost; 2010 Mar; 103(3):564-71. PubMed ID: 20076851
[TBL] [Abstract][Full Text] [Related]
4. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).
Kukuła K; Chojnowska L; Dąbrowski M; Witkowski A; Chmielak Z; Skwarek M; Kądziela J; Teresińska A; Małecki M; Janik P; Lewandowski Z; Kłopotowski M; Wnuk J; Rużyłło W
Am Heart J; 2011 Mar; 161(3):581-9. PubMed ID: 21392615
[TBL] [Abstract][Full Text] [Related]
5. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia.
Vale PR; Losordo DW; Milliken CE; Maysky M; Esakof DD; Symes JF; Isner JM
Circulation; 2000 Aug; 102(9):965-74. PubMed ID: 10961959
[TBL] [Abstract][Full Text] [Related]
7. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease.
Kukuła K; Urbanowicz A; Kłopotowski M; Dąbrowski M; Pręgowski J; Kądziela J; Chmielak Z; Witkowski A; Rużyłło W
Am Heart J; 2019 Sep; 215():78-82. PubMed ID: 31288177
[TBL] [Abstract][Full Text] [Related]
9. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia.
Vale PR; Losordo DW; Milliken CE; McDonald MC; Gravelin LM; Curry CM; Esakof DD; Maysky M; Symes JF; Isner JM
Circulation; 2001 May; 103(17):2138-43. PubMed ID: 11331253
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.
Grines CL; Watkins MW; Mahmarian JJ; Iskandrian AE; Rade JJ; Marrott P; Pratt C; Kleiman N;
J Am Coll Cardiol; 2003 Oct; 42(8):1339-47. PubMed ID: 14563572
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping.
Gyöngyösi M; Khorsand A; Sochor H; Sperker W; Strehblow C; Graf S; Binder T; Glogar D
Am J Cardiol; 2005 Mar; 95(6):722-8. PubMed ID: 15757597
[TBL] [Abstract][Full Text] [Related]
12. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.
Losordo DW; Vale PR; Hendel RC; Milliken CE; Fortuin FD; Cummings N; Schatz RA; Asahara T; Isner JM; Kuntz RE
Circulation; 2002 Apr; 105(17):2012-8. PubMed ID: 11980678
[TBL] [Abstract][Full Text] [Related]
13. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
[TBL] [Abstract][Full Text] [Related]
14. Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.
Sarkar N; Rück A; Källner G; Y-Hassan S; Blomberg P; Islam KB; van der Linden J; Lindblom D; Nygren AT; Lind B; Brodin LA; Drvota V; Sylvén C
J Intern Med; 2001 Nov; 250(5):373-81. PubMed ID: 11887971
[TBL] [Abstract][Full Text] [Related]
15. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.
Stewart DJ; Hilton JD; Arnold JM; Gregoire J; Rivard A; Archer SL; Charbonneau F; Cohen E; Curtis M; Buller CE; Mendelsohn FO; Dib N; Page P; Ducas J; Plante S; Sullivan J; Macko J; Rasmussen C; Kessler PD; Rasmussen HS
Gene Ther; 2006 Nov; 13(21):1503-11. PubMed ID: 16791287
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris.
Sylvén C; Sarkar N; Rück A; Drvota V; Hassan SY; Lind B; Nygren A; Källner Q; Blomberg P; van der Linden J; Lindblom D; Brodin LA; Islam KB
Coron Artery Dis; 2001 May; 12(3):239-43. PubMed ID: 11352080
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
[TBL] [Abstract][Full Text] [Related]
20. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs.
Crottogini A; Meckert PC; Vera Janavel G; Lascano E; Negroni J; Del Valle H; Dulbecco E; Werba P; Cuniberti L; Martínez V; De Lorenzi A; Telayna J; Mele A; Fernández JL; Marangunich L; Criscuolo M; Capogrossi MC; Laguens R
Hum Gene Ther; 2003 Sep; 14(14):1307-18. PubMed ID: 14503966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
